Vaso Occlusive Crisis

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pierre Fabre
Pierre FabreFrance - Aignan
1 program
Validation of a Predictive Score of Acute Chest SyndromeN/A1 trial
Active Trials
NCT03032055UnknownEst. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pierre FabreValidation of a Predictive Score of Acute Chest Syndrome

Clinical Trials (1)

NCT03032055Pierre FabreValidation of a Predictive Score of Acute Chest Syndrome

Validation of a Predictive Score of Acute Chest Syndrome

Start: Jan 2016Est. completion: Dec 2023
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space